N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis

Biomarker-guided treatments are needed in psychiatry, and previous data suggest oxidative stress may be a target in schizophrenia. A previous add-on trial with the antioxidant N-acetylcysteine (NAC) led to negative symptom reductions in chronic patients. We aim to study NAC’s impact on symptoms and...

Descripción completa

Detalles Bibliográficos
Autores principales: Conus, Philippe, Seidman, Larry J, Fournier, Margot, Xin, Lijing, Cleusix, Martine, Baumann, Philipp S, Ferrari, Carina, Cousins, Ann, Alameda, Luis, Gholam-Rezaee, Mehdi, Golay, Philippe, Jenni, Raoul, Woo, T -U Wilson, Keshavan, Matcheri S, Eap, Chin B, Wojcik, Joanne, Cuenod, Michel, Buclin, Thierry, Gruetter, Rolf, Do, Kim Q
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815074/
https://www.ncbi.nlm.nih.gov/pubmed/29462456
http://dx.doi.org/10.1093/schbul/sbx093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815074/
https://www.ncbi.nlm.nih.gov/pubmed/29462456
http://dx.doi.org/10.1093/schbul/sbx093

Ejemplares similares